Patents by Inventor Adam James Musgrave Burrell

Adam James Musgrave Burrell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9499520
    Abstract: The present invention provides a process for preparing a compound of formula: (Formula XI and XII) (XI) (XII) wherein X, Y, Z, A, B and E are as defined herein, by reacting a compound of formula: (Formula XIII) (XIII) with a compound of formula: (Formula XIV and XV) (XIV) (XV) respectively, in the presence of a transition metal catalyst, a ligand suitable for use with 15 the catalyst and a reducing agent. The invention also provides novel intermediates.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: November 22, 2016
    Assignee: Pfizer Ireland Pharmaceuticals
    Inventors: Adam James Musgrave Burrell, Padraig Mary O'Neill, Alan John Pettman
  • Publication number: 20160229842
    Abstract: The present invention provides a process for preparing a compound of formula: (Formula XI and XII) (XI) (XII) wherein X, Y, Z, A, B and E are as defined herein, by reacting a compound of formula: (Formula XIII) (XIII) with a compound of formula: (Formula XIV and XV) (XIV) (XV) respectively, in the presence of a transition metal catalyst, a ligand suitable for use with 15 the catalyst and a reducing agent. The invention also provides novel intermediates.
    Type: Application
    Filed: April 20, 2016
    Publication date: August 11, 2016
    Inventors: Adam James Musgrave Burrell, Padraig Mary O'Neill, Alan John Pettman
  • Patent number: 9388167
    Abstract: The present invention provides a process for preparing a compound of formula: (Formula XI and XII) (XI) (XII) wherein X, Y, Z, A, B and E are as defined herein, by reacting a compound of formula: (Formula XIII) (XIII) with a compound of formula: (Formula XIV and XV) (XIV) (XV) respectively, in the presence of a transition metal catalyst, a ligand suitable for use with 15 the catalyst and a reducing agent. The invention also provides novel intermediates.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: July 12, 2016
    Assignee: Pfizer Ireland Pharmaceuticals
    Inventors: Adam James Musgrave Burrell, Padraig Mary O'Neill, Alan John Pettman
  • Publication number: 20150239867
    Abstract: The present invention provides a process for preparing a compound of formula: (Formula XI and XII) (XI) (XII) wherein X, Y, Z, A, B and E are as defined herein, by reacting a compound of formula: (Formula XIII) (XIII) with a compound of formula: (Formula XIV and XV) (XIV) (XV) respectively, in the presence of a transition metal catalyst, a ligand suitable for use with 15 the catalyst and a reducing agent. The invention also provides novel intermediates.
    Type: Application
    Filed: October 8, 2013
    Publication date: August 27, 2015
    Applicant: Pfizer Ireland Pharmaceuticals
    Inventors: Adam James Musgrave Burrell, Padraig Mary O'Neill, Alan John Pettman